Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesVascular/Cardiothoracic SurgeryHealthSpring Pelvic Embolization Coverage | OpenPa…
    Ask Trek AI about this page
    ModifiedHealthSpringPolicy SUR701.015

    Therapeutic Embolization and Vessel Occlusion to Treat Pelvic Conditions

    Customize your policy alerts

    Sign up for healthspring Policy SUR701.015 alerts

    Get alerted when Policy SUR701.015 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs when transcatheter therapeutic embolization or vessel occlusion may be considered medically necessary for selected pelvic conditions, including uterine fibroids, postpartum hemorrhage, symptomatic varicocele, and pelvic congestion syndrome. Coverage is subject to stated clinical criteria and documentation, the member’s benefit plan, and applicable state requirements.

    Policy Summary
    PayerHealthSpring
    PolicyTherapeutic Embolization and Vessel Occlusion to Treat Pelvic Conditions
    Policy CodePolicy SUR701.015
    Change TypeModified
    Effective DateMay 7, 2026
    Next Review DateN/A
    Key ActionDocument all required criteria for pelvic congestion syndrome, including gynecologic evaluation, at least 6 months of continuous chronic pelvic pain, and diagnostic venography, CT, or MRI.
    SourceLink
    POLICY UPDATE CHANGES

    A new medical policy was issued stating that transcatheter therapeutic embolization or vessel occlusion may be medically necessary when the Coverage criteria are met.

    6 monthsPelvic pain duration
    1 repeat

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Repeat embolization limit
    9CPT codes listed
    Class AConsensus recommendation

    Medical Necessity Criteria

    Uterine fibroid embolization

    Transcatheter therapeutic embolization or vessel occlusion may be considered medically necessary for uterine artery treatment of uterine fibroids when the procedure is performed for at least one qualifying indication.

    Covered procedure

    • Qualifying uterine fibroid indication

      • Excessive uterine bleeding: Heavy, irregular, and prolonged uterine bleeding or iron deficiency
      • Pelvic discomfort caused by leiomyomata, including acute severe pain, chronic lower abdominal pain, low back pressure, or bladder pressure with urinary frequency not due to urinary tract infection
      • Palpable asymptomatic fibroids: Asymptomatic fibroids are sufficiently large to be palpable abdominally and are of concern to the patient

    Postpartum hemorrhage

    Uterine artery embolization may be considered medically necessary for treatment of postpartum hemorrhage.

    Postpartum hemorrhage: Uterine artery transcatheter therapeutic embolization or vessel occlusion is performed to treat postpartum hemorrhage

    Repeat treatment for persistent fibroid symptoms

    One repeat transcatheter therapeutic embolization or vessel occlusion of the uterine arteries may be considered medically necessary after initial uterine artery embolization when continued symptoms are documented.

    Repeat uterine artery embolization: Persistent uterine fibroid symptoms continue after an initial uterine artery embolization and continued symptoms are documentedOne repeat procedure

    Symptomatic varicocele

    Testicular vein embolization, also called gonadal vein embolization, may be considered medically necessary as treatment for symptomatic varicocele.

    Symptomatic varicocele: The patient has a symptomatic varicocele and undergoes testicular or gonadal vein embolization

    Pelvic congestion syndrome or pelvic vein incompetence

    Ovarian vein embolization, with or without internal iliac vein embolization, may be considered medically necessary for pelvic congestion syndrome or pelvic vein incompetence when all criteria are met and documented in the medical record.

    • Required criteria

      • Gynecologic evaluation: Evaluation by a gynecologist has been performed
      • Chronic pelvic pain: Continuous chronic pelvic pain is present for 6 months or moreAt least 6 months
      • Diagnostic testing: Diagnostic venography, computed tomography, or magnetic resonance imaging has been performedVenography, CT, or MRI

    Therapeutic embolization for hemorrhage or other amenable conditions

    CMS coverage guidance supports therapeutic embolization when the procedure is reasonable and necessary for the individual patient.

    Therapeutic embolization coverage guidance: Therapeutic embolization is performed for hemorrhage or another condition amenable to treatment by the procedure and is reasonable and necessary for the individual patient

    Pelvic congestion syndrome

    Consensus recommendations support embolization for pelvic congestion syndrome after clinical and diagnostic validation.

    Pelvic congestion syndrome consensus criteria: Pelvic congestion syndrome is identified by chronic pelvic pain lasting more than six months with a venous pattern, after appropriate diagnostic correlation, and embolization is used as the primary treatment modeMore than 6 months

    Consensus recommendations are Class A; gynecologic examination and evaluation of relevant clinical signs are recommended to exclude conditions requiring specific preoperative management.

    Scope limitation: Transcatheter embolization for indications other than those specifically listed in this policy is not addressed.

    Future fertility: Uterine artery embolization is not advised for patients wishing to preserve future fertility because it may be associated with decreased fertility, a higher miscarriage rate, and adverse pregnancy outcomes.

    Procedure Coding

    CPT CodesCPT
    36012
    36245
    36246
    36247
    37241
    37242
    37243
    37244
    75894
    HCPCS CodesHCPCS
    No codes listed
    CPT CodesCPT
    36012CPT code 36012
    36245CPT code 36245
    36246CPT code 36246
    36247CPT code 36247
    37241CPT code 37241
    37242CPT code 37242
    37243CPT code 37243
    37244CPT code 37244
    75894CPT code 75894
    HCPCS CodesHCPCS
    No codes listed
    Chronic pelvic pain duration
    Duration thresholdMore than six months
    Clinical conditionContinuous chronic pelvic pain
    Associated patternVenous pattern consistent with pelvic congestion syndrome

    Documentation and Denial Risks

    Documentation Required

    Document a Qualifying Fibroid Indication

    Document at least one qualifying uterine fibroid indication before requesting uterine artery embolization. The record must show excessive uterine bleeding or a qualifying fibroid-related symptom/finding.

    • Heavy, irregular, and prolonged uterine bleeding, or iron deficiency.
    • Pelvic discomfort caused by leiomyomata, including acute severe pain, chronic lower abdominal pain, low back pressure, or bladder pressure with urinary frequency not due to a urinary tract infection.
    • Asymptomatic fibroids that are palpable abdominally and are of concern to the patient.
    Documentation Required

    Document Continued Symptoms for Repeat Treatment

    For one repeat transcatheter therapeutic embolization or vessel occlusion of the uterine arteries after an initial uterine artery embolization, document that fibroid symptoms have persisted or continued.

    • Link the repeat procedure to persistent symptoms of uterine fibroids after the initial embolization.

    Clinical Background

    Therapeutic embolization or vessel occlusion intentionally blocks a blood vessel by placing particulate, liquid, mechanical, or autologous blood-clot agents inside the vessel. The occlusion may be performed in arteries, veins, or capillary beds and may be temporary or permanent.

    Key Terms

    Therapeutic occlusion or embolization
    DefinitionIntravascular deposition of particulate liquid, mechanical agents, or autologous blood clot to produce intentional vessel blockage
    Vessel levelsMay be performed in large arteries, large veins, or capillary beds
    DurationEmbolic vascular occlusion may be temporary or permanent
    Pelvic congestion syndrome
    DefinitionA chronic pelvic pain syndrome associated with pelvic venous abnormalities
    Venous abnormalitiesMay include ovarian vein varices or pelvic venous congestion
    Diagnostic consideration
    Policy Summary
    PayerHealthSpring
    PolicyTherapeutic Embolization and Vessel Occlusion to Treat Pelvic Conditions
    Policy CodePolicy SUR701.015
    Change TypeModified
    Effective DateMay 7, 2026
    Next Review DateN/A
    Key ActionDocument all required criteria for pelvic congestion syndrome, including gynecologic evaluation, at least 6 months of continuous chronic pelvic pain, and diagnostic venography, CT, or MRI.
    SourceLink
    On This Page
    Medical Necessity CriteriaProcedure CodingDocumentation and Denial RisksClinical BackgroundKey Terms
  1. Include the continued symptoms in the medical record before requesting repeat treatment.
  2. Documentation Required

    Document the Pelvic Congestion Syndrome Workup

    For ovarian vein embolization, with or without internal iliac vein embolization, to treat pelvic congestion syndrome or pelvic vein incompetence, document every required criterion in the medical record. Coverage requires all criteria, not just a suspected diagnosis.

    • Evaluation by a gynecologist.
    • Continuous chronic pelvic pain for 6 months or more.
    • Diagnostic venography, computed tomography, or magnetic resonance imaging.
    Documentation Required

    Document Supportive Pelvic Venous Symptoms

    When documenting pelvic congestion syndrome, capture clinically relevant associated signs and symptoms that support the diagnosis and medical-necessity assessment.

    • Symptoms worsening with prolonged standing or sitting.
    • Evening exacerbation.
    • Relief with rest in the lying-down position.
    • Relief after raising the legs.
    • Visible varicosities, such as perineal, vulvular, or gluteal varicosities.
    Note

    Indication Outside Policy Scope

    Transcatheter embolization for indications not addressed in this policy is outside the policy scope and is not addressed for coverage determination.

    • Do not assume coverage for an unlisted indication based on this policy.
    • Obtain and apply the applicable policy or coverage guidance for the requested indication.
    Denial Risk

    Incomplete Pelvic Congestion Syndrome Criteria

    Pelvic congestion syndrome criteria are incomplete unless all specified requirements are documented. Missing any one required element may prevent the procedure from meeting the policy criteria.

    • Document evaluation by a gynecologist.
    • Document continuous chronic pelvic pain for at least 6 months.
    • Document diagnostic venography, computed tomography, or magnetic resonance imaging.
    • Also record relevant supportive findings when present, including positional or evening worsening, relief when lying down or after leg elevation, and visible perineal, vulvular, or gluteal varicosities.
    Denial Risk

    Repeat Procedure Without Documented Persistent Symptoms

    A repeat uterine artery embolization is not supported unless the record documents persistent or continued uterine fibroid symptoms after the initial embolization.

    • Document the initial uterine artery embolization.
    • Describe the symptoms that continued or recurred after the initial procedure.
    • Do not submit the repeat procedure without evidence of persistent symptoms.
    Other causes of chronic pelvic pain may need to be excluded; gynecologic examination is recommended
    Uterine leiomyomata
    DefinitionBenign uterine tumors
    LocationsMay be submucosal, intramural, or subserosal
    Associated symptomsMay cause heavy menstrual bleeding, pelvic pain, urinary frequency, or other symptoms
    Varicocele
    DefinitionDilated or enlarged veins in the scrotum
    SymptomsMay cause a visible or palpable enlarged vein, aching scrotal pain, or a feeling of heaviness in the testicles
    Potential complicationsMay be associated with testicular atrophy, changes in testosterone levels, urinary problems, or infertility issues